Solvias Constructs New Building in Kaiseraugst

The Board of Directors of Solvias AG in Basel has decided to build a new headquarters in Kaiseraugst. The preliminary contract to buy the land was signed at the start of January 2008, with construction work due to start in a few months’ time.

Solvias AG is preparing for further growth by building the planned new offices and laboratory. This is a big step forward in the company's near ten-year history. In addition to creating space for growth, it will also enable Solvias to nurture its independent culture in its own building more intensively. New jobs will be created in the attractive working and residential environment of Römergarten in the Fricktal region. As a reliable partner for the Life Science industry, Solvias will fit in well with the existing companies in the area, Roche and DSM.

The functional yet elegant new building has been designed by the Basel architects Zwimpfer Partner and the laboratory and offices will be able to accommodate up to 300 modern workplaces . An additional area of land has been contractually secured for further growth. The move to Kaiseraugst is due to take place in mid-2010. The synthesis and catalysis business segment, which employs around 50 people, will not move but will remain in its current location at Rosental in Basel-Stadt.

"The new building in Kaiseraugst is an important strategic decision for the development of the company. Our future requirements will be very well met by the location and the project. This will enable us to react flexibly to changing market conditions and customer requirements," said Hansjörg Walther, CEO of Solvias AG. "The local community and the canton of Aargau offer ideal conditions for the future development of Solvias."

Solvias is a privately held company located in Basel/Switzerland. With 280 highly qualified employees we support the research and development of new drug substances and the optimization of manufacturing processes for pharmaceutical and biotechnology companies worldwide. Solvias’ customers benefit from a wide range of experience in catalysis, asymmetric synthesis, custom synthesis, process R&D, polymorphism screening, salt selection, and analytical services.